Serum levels of oncostatin M (a gp 130 cytokine): An inflammatory biomarker in periodontal disease

Biomarkers

Volumn 15, Issue 3, 2010, Pages 277-282

  Pradeep, A R ^a   Thorat Manojkumar, S ^a   Garima, Garg ^a   Raju, Arjun ^b  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Bangalore Medical College and Research Institute   (India)

Author keywords

Cytokines; Gingivitis; Inflammatory biomarker; Oncostatin M; Periodontitis; Serum

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN GP 130; ONCOSTATIN M;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PERIODONTAL DISEASE; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE;

ADULT; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMANS; INFLAMMATION; MALE; ONCOSTATIN M; PERIODONTAL DISEASES; RISK FACTORS;

EID: 77951676088     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903573209     Document Type: Article

References (36)

1. Abbas AK, Lichtman AH. (2003). Cellular and Molecular Immunology, 5th edn. Philadelphia: Saunders.
2. Beck JD, Ofenbacher S. (2005). Systemic efects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76:2089-2100
3. Brown TJ, Rowe JM, Liu JW, Shoyab M. (1991). Regulation of IL-6 expression by oncostatin M. J Immunol 147:2175-2180
4. Bruce AG, Hoggatt IH, Rose TM. (1992). Oncostatin M is a diferentia-tion factor for myeloid leukemia cells. J Immunol 149:1271-1275
5. Cai J, Gill PS, Masood R, Chandrosoma P, Jung B, Law RE, Radka SF. (1994). Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 145:74-79
6. Ebersole JL, Machen RL, Stefen MJ, Willmann DE (1997). Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 107:347-352
7. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfne A, Libby P, et al. (2009). Te American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 104:59-68.
8. Gemmell E, Seymour GJ. (2004). Immunoregulatory control of T1/T2 cytokine profles in periodontal disease. Periodontol 2000 35:21-41.
9. Goren I, Kampfer H, Muller E, Schiefelbein D, Pfeilschifter J, Frank S. (2006). Oncostatin M expression is functionally connected to neutrophils in the early infammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126:628-637
10. Halin U-R, Agnieszka W, Henryk S, Tadeusz R. (2000). Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncos-tatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Eur Cytokine Netw 11:443-451
11. Hui W, Bell M, Carroll G. (1997). Detection of oncostatin M in syno-vial fuid from patients with rheumatoid arthritis. Ann Rheum Dis 56:184-187
12. Iacopino AM. (2001). Periodontitis and diabetes interrelationships: role of infammation. Ann Periodontol 6:125-137
13. Jefcott MJ, Haut JC, Guers N et al. (2003). Periodontal disease and preterm birth: result of a pilot intervention study. J Periodontol 74:1214.
14. Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO et al. (2005). Periodontitis and airway obstruction. J Periodontol 76:2161-2167
15. Kornman KS, Page RC, Tonetti MS. (1997). Te host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14:33-53.
16. Lin S-J, Chen Y-L, Kuo MY-P, Li C-L, Lu H-K. (2005). Measurement of gp130 cytokine oncostatin M and IL-6 in gingival crevicular fuid of patients with chronic periodontitis. Cytokine 30:160-167
17. Loe H, Silness J. (1963). Perioontal disease in pregnancy. I: Prevalence and severity. Acta Odontol Scand 21:533.
18. Loe H. (1993). Periodontal diseases: sixth complication of diabetes mellitus. Diabetes Care 16 (Suppl. 1):329.
19. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden V. (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528-1534
20. Lopez NJ, Smith PC, Gutierrez J. (2002). Periodontal therapy may reduce the risk of preterm low birth in women with periodontal disease: a randomized controlled trial. J Periodontol 73:911-924
21. Lu H-K, Chen Y-L, Chang H-C, Li C-L, Kuo MY-P. (2006). Identifcation of the OPG/RANKL system in gingival crevicular fuid and tissue of patients with chronic periodontitis. J Periodont Res 41:354-360
22. Malthaner SC, Moore S, Mills M et al. (2002). Investigation of the association between angiographically defned coronary artery disease and periodontal disease. J Periodontol 73:1169.
23. Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Tonar EJ. (2000). Synovial fuid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281-288
24. Mealey BL. (1999). Infuence of periodontal infections on systemic health. Periodontol 2000 21:197
25. Modur V, FeldhausMJ, Weyrich AS et al. (1997). Oncostatin M is a proinfammatory mediator. In vivo efects correlate with endothe-lial cell expression of infammatory cytokines and adhesion molecules. J Clin Invest 100:158-168
26. Ofenbacher S, Katz V, Fertik G et al. (1996). Periodontal disease as a possible risk factor for preterm low birth weight. J Periodontol 67:1103.
27. Orozco A, Gemmell E, Bickel M, Seymour GJ. (2007). Interleukin 18 and periodontal disease. J Dent Res 86:586-593
28. Page RC. (1998). Periodontal diseases: a new paradigm. J Dent Educ 62:812-821
29. Page RC, Beck JD. (1997). Risk assessment for periodontal diseases. Int Dent J 47:61.
30. Paraskevas S, Huizinga JD, Loos BG. (2008). A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35:277-290
31. Sanchez AR, Kupp LI, Sheridan PJ, Sanchez DR. (2004). Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 6:89-94.
32. Scannapieco FA, Bush RB, Paju S. (2003). Association between peri-odontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. J Periodontol 8:38-53.
33. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y. (2002). Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res 91:9-16.
34. Song HY, Kim MR, Lee MJ, Jeon ES, Bae YC, Jung JS et al. (2007). Oncostatin M decreases adiponectin expression and induces dediferentiation of adipocytes by JAK3 and MEK dependent pathways. Int J Biochem Cel Biol 39:439-449
35. Tanimura A, McGregor DH, Anderson HC. (1986). Calcifcation in atherosclerosis. I: Human studies. J Exp Pathol 2:261-273
36. Yao L, Pan J, Setiadi H, Patel KD, McEver RP. (1996). Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184:81-92.